Revive Therapeutics Ltd (RVVTF)
0.017
0.00 (0.00%)
USD |
OTCM |
Jun 03, 16:00
Revive Therapeutics 1 Year Total Returns (Daily): -56.41% for June 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 03, 2024 | -56.41% |
| May 31, 2024 | -58.60% |
| May 30, 2024 | -60.54% |
| May 29, 2024 | -62.53% |
| May 28, 2024 | -57.89% |
| May 24, 2024 | -61.32% |
| May 23, 2024 | -63.27% |
| May 22, 2024 | -63.00% |
| May 21, 2024 | -59.07% |
| May 20, 2024 | -62.39% |
| May 17, 2024 | -51.24% |
| May 16, 2024 | -47.91% |
| May 15, 2024 | -52.44% |
| May 14, 2024 | -48.40% |
| May 13, 2024 | -49.38% |
| May 10, 2024 | -62.19% |
| May 09, 2024 | -62.75% |
| May 08, 2024 | -59.70% |
| May 07, 2024 | -58.02% |
| May 06, 2024 | -58.54% |
| May 03, 2024 | -61.54% |
| May 02, 2024 | -64.88% |
| May 01, 2024 | -64.83% |
| April 30, 2024 | -61.99% |
| April 29, 2024 | -64.03% |
| Date | Value |
|---|---|
| April 26, 2024 | -67.54% |
| April 25, 2024 | -67.30% |
| April 24, 2024 | -62.93% |
| April 23, 2024 | -68.40% |
| April 22, 2024 | -66.75% |
| April 19, 2024 | -67.27% |
| April 18, 2024 | -61.54% |
| April 17, 2024 | -53.71% |
| April 16, 2024 | -58.73% |
| April 15, 2024 | -57.76% |
| April 12, 2024 | -63.77% |
| April 11, 2024 | -63.53% |
| April 10, 2024 | -57.82% |
| April 09, 2024 | -56.03% |
| April 08, 2024 | -56.42% |
| April 05, 2024 | -60.78% |
| April 04, 2024 | -51.36% |
| April 03, 2024 | -51.14% |
| April 02, 2024 | -42.50% |
| April 01, 2024 | -45.50% |
| March 28, 2024 | -42.51% |
| March 27, 2024 | -41.94% |
| March 26, 2024 | -43.87% |
| March 25, 2024 | -42.05% |
| March 22, 2024 | -49.36% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.07%
Minimum
Aug 08 2023
3.43K%
Maximum
Dec 14 2020
88.60%
Average
-46.17%
Median
Jan 20 2022
1 Year Total Returns (Daily) Benchmarks
| Acasti Pharma Inc | -10.18% |
| Aurinia Pharmaceuticals Inc | -43.82% |
| Edesa Biotech Inc | -26.69% |
| Lexaria Bioscience Corp | 422.8% |
| Xenon Pharmaceuticals Inc | -1.46% |